Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Imunon (IMNN)
NASDAQ:IMNN
IMNN Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.53 - $3.65
Previous CloseN/A
Volume151.93K
Average Volume (3M)136.41K
Market Cap
$12.64M
Enterprise Value$6.27M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.30
Next Earnings
Mar 27, 2025EPS Estimate
-0.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.89
Shares Outstanding14,500,685
10 Day Avg. Volume166,058
30 Day Avg. Volume136,409
Standard Deviation0.34
R-Squared0.10
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.50
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-8.70
Enterprise Value/Ebitda-0.31
Forecast
1Y Price Target
$12.00Price Target Upside1279.31% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Imunon News
PremiumCompany Announcements
Imunon Appoints Dr. Douglas Faller as CMO
PremiumCompany Announcements
Imunon, Inc. Reports Q3 2024 Earnings and Progress---
Bulls Say, Bears Say
Bulls Say
Clinical Trial ProgressImproved overall survival hazard ratio and increased survival benefit have been shown with IMNN-001 treatment.
Regulatory ApprovalThe FDA agreed that the company's current manufacturing process and its strategy for ensuring comparability between IMNN-001 produced in-house and that previously produced by an external contractor are acceptable.
Bears Say
Financial ConstraintsThe company has sufficient funding to initiate the Phase 3 program though will need to raise additional capital in 2025.
---
Ownership Overview
4.93% Insiders
1.21% Mutual Funds
4.37% Other Institutional Investors
89.16% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMNN FAQ
What was Imunon’s price range in the past 12 months?
Imunon lowest stock price was $0.53 and its highest was $3.65 in the past 12 months.
What is Imunon’s market cap?
Imunon’s market cap is $12.64M.
When is Imunon’s upcoming earnings report date?
Imunon’s upcoming earnings report date is Mar 27, 2025 which is in 33 days.
How were Imunon’s earnings last quarter?
Imunon released its earnings results on Nov 07, 2024. The company reported -$0.34 earnings per share for the quarter, beating the consensus estimate of -$0.388 by $0.048.
Is Imunon overvalued?
According to Wall Street analysts Imunon’s price is currently Undervalued.
Does Imunon pay dividends?
Imunon does not currently pay dividends.
What is Imunon’s EPS estimate?
Imunon’s EPS estimate is -0.36.
How many shares outstanding does Imunon have?
Imunon has 14,500,685 shares outstanding.
What happened to Imunon’s price movement after its last earnings report?
Imunon reported an EPS of -$0.34 in its last earnings report, beating expectations of -$0.388. Following the earnings report the stock price went down -12.766%.
Which hedge fund is a major shareholder of Imunon?
Currently, no hedge funds are holding shares in IMNN
---
Company Description
Imunon
Celsion Corp . engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.
---
IMNN Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call was generally positive, with notable achievements in clinical trials and strategic advancements overshadowing the financial challenges and increased R&D spending.Read More>---
IMNN Stock 12 Month Forecast
Average Price Target
$12.00
▲(1279.31% Upside)
Technical Analysis
Best Analysts Covering IMNN
1 Year
1 Year Success Rate
4/16 ratings generated profit
1 Year Average Return
-26.06%
assigned a buy rating 2 months ago
Copying Emily Bodnar's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -26.06% per trade.
---